How a Novel Tissue Marker Makes a Difference
Chirag Shah, MD and Zahraa Al-Hilli, MD at the Cleveland Clinic discuss partial breast irradiation (PBI) and the impact of placing the VeraForm® marker for patients receiving radiation treatment after breast-conserving surgery. As a leader in applying this novel technology, the radiation oncology and breast surgery teams at the Cleveland Clinic are incorporating VeraForm with multiple techniques with a goal to decrease recurrence rates while reducing side effects to the heart, lung and breast.
Comments